Anúncio
Anúncio
BIO.B
Bio-Rad Laboratories, Inc. Class B
322.97
USDPatrocinado
+12.27
+3.95%
09 de jan., 15:56 UTC -5
Encerrado
Pós-Mercado
323.64
+0.67
+0.21%
Relatórios de Lucros BIO.B
Rácio de surpresa positiva
BIO.B separação 29 de 40 últimas estimativas.
73%
Próximo Relatório
Data do Próximo Relatório
11 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$705.51M
/$2.77
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+8.04%
/+23.11%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+5.69%
/-4.48%
Bio-Rad Laboratories, Inc. Class B earnings per share and revenue
On 29 de out. de 2025, BIO.B reported earnings of 2.25 USD per share (EPS) for Q3 25, beating the estimate of 1.95 USD, resulting in a 15.74% surprise. Revenue reached 653.00 milhão, compared to an expected 657.81 milhão, with a -0.73% difference.
Looking ahead to Q4 25, 6 analistas forecast an EPS of 2.77 USD, with revenue projected to reach 705.51 milhão USD, implying an aumentar of 23.11% EPS, and aumentar of 8.04% in Revenue from the last quarter.
FAQ
What were Bio-Rad Laboratories, Inc. Class B's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Bio-Rad Laboratories, Inc. Class B reported EPS of $2.25, beating estimates by 15.74%, and revenue of $653.00M, -0.73% below expectations.
How did the market react to Bio-Rad Laboratories, Inc. Class B's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Bio-Rad Laboratories, Inc. Class B expected to report next?
The next earning report is scheduled for 11 de fev. de 2026.
What are the forecasts for Bio-Rad Laboratories, Inc. Class B's next earnings report?
Based on 6
analistas, Bio-Rad Laboratories, Inc. Class B is expected to report EPS of $2.77 and revenue of $705.51M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio